Patent US1469269A successfully refreshed from Google Patents.
Patent US4325946A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4325946A Expired / Lapsed US ⏱️ 0.0 years remaining

Anthracycline glycosides, their preparation, use and compositions thereof

Assignee: Pfizer Italia SRL
•
Filing: 1980-08-28
•
Granted: 1982-04-20
•
Expires: 2000-08-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Anthracycline glycosides of the formula I <IMAGE> I wherein R is hydrogen or hydroxy, one of R1 and R2 is methyl and the other of R1 and R2 is hydroxy, and pharmaceutically acceptable acid addition salts thereof, which are useful in treating certain mammalian tumors, are prepared by condensing daunomycinone with certain novel sugars in an inert organic solvent and in the presence of a soluble silver salt and a dehydrating agent to form the corresponding protected glycosides from which the protecting groups are removed. This gives the compounds wherein R is hydrogen. The former are converted to the corresponding hydroxyl compounds by treatment with bromine and sodium formate.

Inventors

  • 👤 Alberto Bargiotti
  • 👤 Giueseppe Cassinelli
  • 👤 Sergio Penco
  • 👤 Federico Arcamone
  • 👤 Aurelio Di Marco

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-30 21:58
CPC Classifications
C; C07; C07H; C07H13/00; C07H13/02; C07H13/08; A; A61; A61P; A61P35/00; A61P35/02; C07H15/00; C07H15/20; C07H15/24; C07H15/252; Y; Y02; Y02P; Y02P20/00; Y02P20/50; Y02P20/55

Claims Analysis

Total Claims: 16
Claim 1
Independent Claim 40 words
An anthracycline glycoside of the formula: ##STR7## wherein R is hydrogen or hydroxy, one of R 1 and R 2 is methyl and the other of R 1 and R 2 is hydroxy, and pharmaceutically acceptable acid addition salts thereof.
Claim 2
Dependent Claim 40 words
An anthracycline glycoside of the formula: ##STR7## wherein R is hydrogen or hydroxy, one of R 1 and R 2 is methyl and the other of R 1 and R 2 is hydroxy, and pharmaceutically acceptable acid addition salts thereof.
Claim 3
Dependent Claim 10 words
An anthracycline glycoside according to claim 1, which is 4'-C-methyl-daunorubicin.
Claim 4
Dependent Claim 10 words
An anthracycline glycoside according to claim 1, which is 4'-C-methyl-doxorubicin.
Claim 5
Dependent Claim 10 words
An anthracycline glycoside according to claim 1, which is 4'-epi-4'-C-methyl-daunorubicin.
Claim 6
Dependent Claim 10 words
An anthracycline glycoside according to claim 1, which is 4'-epi-4'-C-methyl-doxorubicin.
Claim 7
Dependent Claim 41 words
A sugar of the formula: ##STR8## wherein X is hydroxyl, chloro or p-nitrobenzoyl, R 1 is methyl, or p-nitrobenzoyl and R 2 is methyl, or p-nitrobenzoyl, wherein one of R 1 and R 2 is methyl and the other is P-nitrobenzoyl.
Claim 8
Dependent Claim 41 words
A sugar of the formula: ##STR8## wherein X is hydroxyl, chloro or p-nitrobenzoyl, R 1 is methyl, or p-nitrobenzoyl and R 2 is methyl, or p-nitrobenzoyl, wherein one of R 1 and R 2 is methyl and the other is P-nitrobenzoyl.
Claim 9
Dependent Claim 19 words
A sugar according to claim 6 wherein X is chloro, R 1 is methyl and R 2 is p-nitrobenzoyl.
Claim 10
Dependent Claim 19 words
A sugar according to claim 6 wherein X is chloro, R 1 is p-nitrobenzoyl and R 2 is methyl.
Claim 11
Dependent Claim 19 words
A sugar according to claim 6 wherein X is p-nitrobenzoyl, R 1 is methyl and R 2 is p-nitrobenzoyl.
Claim 12
Dependent Claim 19 words
A sugar according to claim 6 wherein X is p-nitrobenzoyl, R 1 is p-nitrobenzoyl and R 2 is methyl.
Claim 13
Dependent Claim 125 words
A process for preparing the sugars according to claim 6 wherein X is chloro, one of R 1 and R 2 is methyl and the other is p-nitrobenzoyl, said process comprising separately subjecting 2,3,6-trideoxy-4-C-methyl-α-L-lyxo-hexopyranose(IV-A) and 2,3,6-trideoxy-4-C-methyl-α-L-arabinohexopyranose (IV-B) to acid hydrolysis to form respectively, sugars wherein X is hydroxy, one of R 1 and R 2 is methyl and the other is hydroxy, reacting each said sugar with p-nitrobenzoyl chloride to form the sugars wherein X is p-nitrobenzoyl, one of R 1 and R 2 is methyl and the other is p-nitrobenzoyl, and separately subjecting each said sugar to treatment with anhydrous hydrogen chloride to form said sugars wherein X is chloro, one of R 1 and R 2 is methyl and the other is p-nitrobenzoyl.
Claim 14
Dependent Claim 63 words
A process according to claim 11 wherein the acid hydrolysis is effected with acetic acid at about 100° C. for about 2 hours, the reaction with p-nitrobenzoyl chloride is effected in the presence of triethylamine and a catalytic amount of 4-dimethylamino pyridine at about 45° C. for about 1.5 hours and the treatment with anhydrous hydrogen chloride is effected at about 0° C.
Claim 15
Dependent Claim 29 words
An antitumor pharmaceutical composition, for a transplanted tumor, comprising a therapeutically effective amount of an anthracycline glycoside as claimed in claim 1 in combination with an inert carrier therefor.
Claim 16
Dependent Claim 32 words
A method of inhibiting the growth of transplanted P 388 leukemia comprising intraperitoneally administering to a host afflicted therewith, a therapeutically effective amount of an anthracycline glycoside as claimed in claim 1.

References Cited (Backward Citations)

US3803124A Cited
US4046878A Cited
US4112076A Cited
US4067969A Cited
US4133877A Cited
US4191755A Cited
US4265885A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1985-04-19 1985-10-19 1986-04-20 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1989-04-19 1989-10-19 1990-04-20 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1993-04-19 1993-10-19 1994-04-20 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag